The UK’s Prescription Medicines Code of Practice Authority (PMCPA) issued its final resolution in a 2025 case following a voluntary admission by Pfizer, concluding that the company failed to maintain high standards, certify required materials, and ensure appropriate hospitality.
The PMCPA case identifies multiple breaches of the Association of